Lawrence E. Bloch

2013

In 2013, Lawrence E. Bloch earned a total compensation of $1.1M as Chief Financial Officer and Chief Business Officer at Infinity Pharmaceuticals, a 48% decrease compared to previous year.

Compensation breakdown

Option Awards$703,727
Salary$378,800
Other$8,280
Total$1,090,807

Bloch received $703.7K in option awards, accounting for 65% of the total pay in 2013.

Bloch also received $378.8K in salary and $8.3K in other compensation.

Rankings

In 2013, Lawrence E. Bloch's compensation ranked 6,216th out of 12,286 executives tracked by ExecPay. In other words, Bloch earned more than 49.4% of executives.

ClassificationRankingPercentile
All
6,216
out of 12,286
49th
Division
Manufacturing
2,171
out of 4,612
53rd
Major group
Chemicals And Allied Products
645
out of 1,462
56th
Industry group
Drugs
466
out of 1,156
60th
Industry
Pharmaceutical Preparations
373
out of 890
58th
Source: SEC filing on April 25, 2016.

Bloch's colleagues

We found four more compensation records of executives who worked with Lawrence E. Bloch at Infinity Pharmaceuticals in 2013.

2013

Adelene Perkins

Infinity Pharmaceuticals

Chief Executive Officer

2013

Julian Adams

Infinity Pharmaceuticals

President of R&D

2013

Vito Palombella

Infinity Pharmaceuticals

Chief Scientific Officer

2013

David Roth

Infinity Pharmaceuticals

Chief Medical Officer

News

In-depth

You may also like